Panacea Biotech up 15% on fund raising plan, demerger of real estate biz
The stock hit a 52-week high of Rs 254, up 15% on BSE in early morning trade11-09-2017
11-09-2017
Updates
Notice of Board Meeting under Regulation 29 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 201509-09-2017
Fixes Book Closure for AGM (Cut-off date for e-voting)
Panacea Biotec Ltd has informed BSE that the Register of Members & Share Transfer Books of the Company will remain closed from September 20, 2017 to September 27, 2017 (both days inclusive) for the purpose of 33rd Annual General Meeting (AGM) of the Company to be held on September 27, 2017.05-09-2017
Annual General Meeting On September 27, 2017
We would like to inform you that the 33rd AGM of Panacea Biotec Limited is scheduled to be held on Wednesday, September 27, 2017 at 11:30 A.M. at the Registered Office. Pursuant to the provisions of Section 108 of the Act read with Rule 20 of the Companies (Management and Administration) Rules, 2014, and Regulation 44 of the SEBI LODR,2015,the Company is pleased to provide remote e-voting facility to its members to cast their votes electronically....01-09-2017
Board Meeting Of Panacea Biotec Ltd. Is To Be Held On 13Th September, 2017 For Approving The Unaudited Financial Results (Provisional) For The Quarter Ended 30Th June, 2017
This is to inform you that a Meeting of the Board of Directors of Panacea Biotec Ltd. is scheduled to be held on Wednesday, 13th September, 2017 at New Delhi, inter-alia, to consider and approve the Unaudited Financial Results (Provisional) for the quarter ended 30th June, 2017.30-08-2017
Panacea promoters may demerge real estate business into separate firm
Panacea Biotec said its promoters plan to demerge the company's real estate business into a separate firm to be later listed on bourses30-08-2017
Memorandum of Understanding /Agreements
Panacea Biotec Limited has received today a letter dated August 29, 2017 from the promoters of the Company, that they have entered into a Memorandum of Acknowledgement of Oral Family Settlement with regard to the overall control and management of the Company and its subsidiaries.30-08-2017
Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011
The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Serum Institute of India Pvt Ltd18-08-2017
Updates
Panacea Biotec Ltd., in accordance with the SEBI Circular No. CIR/CFD/FAC/62/2016 dated July 05, 2016, would be availing extension of one month and will submit the financial results for the quarter ended June 30, 2017 on or before September 14, 2017.09-08-2017
Panacea Biotec, US' Bionpharma join hands for manufacture of 7 drugs
Drug firm Panacea Biotec today said it has entered into a joint collaboration with the US's Bionpharma for development, licence, manufacturing, supply and sales of seven complex generic products....28-07-2017